Mci-186

Thông số

89-25-8Số CAS

201-891-0Số EC

5-methyl-2-phenyl-4H-pyrazol-3-oneTên IUPAC

C10H10N2OCông thức hóa học

174.2 g/molKhối lượng phân tử

MCI-186; MCI 186; RefChem:57584; edaravone; 89-25-8; 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE; Radicut; Norphenazone; 1-Phenyl-3-methyl-5-pyrazolone; Developer Z; Methylphenylpyrazolone; Norantipyrine; C.I. Developer 1; Phenylmethylpyrazolone; Phenyl methyl pyrazolone; Radicava; 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one; 3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one; 3-Methyl-1-phenyl-2-pyrazoline-5-one; 5-methyl-2-phenyl-4H-pyrazol-3-one; 1-Phenyl-3-methyl-5-oxo-2-pyrazoline; 3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-; 1-Phenyl-3-methylpyrazolone; 2-Pyrazolin-5-one, 3-methyl-1-phenyl-; 1-Phenyl-3-methylpyrazolone-5; 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one; Edaravone (MCI-186); 3-Methyl-1-phenylpyrazol-5-one; NCI-C03952; 5-Pyrazolone, 3-methyl-1-phenyl-; MFCD00003138; DTXSID9021130; Colorex pmp; Jarocol pmp; NSC-2629; 1-Fenyl-3-methyl-2-pyrazolin-5-on; NSC-26139; 3-methyl-1-phenyl-4,5-dihydro-1H-pyrazol-5-one; 1-Phenyl-3-methyl-5-pyrazolinone; S798V6YJRP; MLS000069602; 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE (MCI-186); CHEBI:31530; s1326; CI Developer 1; NCGC00164015-01; SMR000059020; Edaravone [INN]; DTXCID201130; Monopyrazolone; WLN: T5NMV DHJ BR& E1; 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one (Edaravone); CAS-89-25-8; CCRIS 512; Radicut (TN); HSDB 4102; 3H-Pyrazol-3-one,4-dihydro-5-methyl-2-phenyl-; SR-01000000135; 1-Fenyl-3-methyl-2-pyrazolin-5-on [Czech]; EINECS 201-891-0; UNII-S798V6YJRP; BRN 0609575; edaravona; 3-?Methyl-?1-?phenyl-?2-?pyrazolin-?5-?one(Edaravone); AI3-03557; MCI186; (Edaravone); Radicava (TN); (MCI-186); Edaravone (Standard); CDS1_000986; Spectrum_000267; Tocris-0786; EDARAVONE [JAN]; MCI-186; Edaravone; Edaravone [USAN:INN]; EDARAVONE [HSDB]; EDARAVONE [USAN]; Maybridge1_005738; Opera_ID_1057; Spectrum2_001574; Spectrum3_000971; Spectrum4_001091; Spectrum5_001217; NORPHENAZONE [MI]; Phenazone impurity A CRS; M0687; EDARAVONE [MART.]; EC 201-891-0; EDARAVONE [WHO-DD]; SCHEMBL4704; BSPBio_001235; BSPBio_002601; KBioGR_000575; KBioGR_001502; KBioSS_000575; KBioSS_000747; AE-641/00371017; MLS001146878; MLS002415675; MLS006011753; DivK1c_001018; DivK1c_002026; SCHEMBL148321; SPECTRUM1503635; SPBio_001508; CHEMBL290916; orb1223731; orb1310644; orb3139607; SCHEMBL4099403; SCHEMBL8935505; SCHEMBL9439001; Edaravone (USAN/JP18/INN); EDARAVONE [ORANGE BOOK]; BCBcMAP01_000127; GTPL11994; HMS503K17; HMS557M18; HY-B0099R; KBio1_001018; KBio2_000575; KBio2_000747; KBio2_003143; KBio2_003315; KBio2_005711; KBio2_005883; KBio3_001029; KBio3_001030; KBio3_001821; NSC2629; NINDS_001018; Bio1_000438; Bio1_000927; Bio1_001416; Bio2_000448; Bio2_000928; GLXC-05042; HMS1362M17; HMS1792M17; HMS1990M17; HMS2234M19; HMS3266F04; HMS3403M17; HMS3411L05; HMS3654L15; HMS3675L05; HMS3884A11; HMS5079B11; Pharmakon1600-01503635; DZB76567; HY-B0099; NSC26139; Tox21_112077; Tox21_201747; Tox21_302819; BDBM50200541; CCG-39352; EBC-03526; MSK000657; NSC758622; STK201315; 1-Phenyl-3-methyl-2-pyrazolin-5-on; AKOS000313817; Tox21_112077_1; AC-4745; CS-1832; DB12243; FE22642; NSC-758622; SB19128; IDI1_001018; IDI1_002203; NCGC00018218-01; NCGC00018218-02; NCGC00018218-03; NCGC00018218-04; NCGC00018218-05; NCGC00018218-06; NCGC00018218-07; NCGC00018218-08; NCGC00018218-10; NCGC00018218-11; NCGC00018218-16; NCGC00018218-17; NCGC00022665-02; NCGC00022665-04; NCGC00022665-05; NCGC00022665-06; NCGC00256515-01; NCGC00259296-01; ST012744; SY008808; PHENAZONE IMPURITY A [EP IMPURITY]; SBI-0051836.P002; DB-002517; NS00002708; SW148216-2; 5-methyl-2-phenyl-2,4-dihydro-3-pyrazolone; EN300-16234; 3-Methyl-1-phenyl-2-pyrazoline-5-one, 99%; 4E-901; 5-methyl-2-phenyl-2,4-dihydro-pyrazol-3-one; D01552; D86209; 3-?Methyl-?1-?phenyl-?2-?pyrazolin-?5-?one; AB00375776_14; AB00375776_15; 2 4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one; 2,4-dihydro-2-phenyl-5-methyl-3H-pyrazol-3-one; F038216; Q335099; SR-01000000135-2; SR-01000000135-3; SR-01000000135-5; 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one #; BRD-K35458079-001-04-2; BRD-K35458079-001-12-5; BRD-K35458079-001-23-2; BRD-K35458079-001-27-3; BRD-K35458079-001-28-1; BRD-K35458079-001-29-9; BRD-K35458079-001-31-5; BRD-K35458079-001-33-1; Z50145861; F0391-0021; 3-Methyl-1-phenyl-2-pyrazoline-5-one, SAJ special grade; 3-Methyl-1-phenyl-2-pyrazoline-5-one, purum, >=98.0% (NT); Phenazone impurity A, European Pharmacopoeia (EP) Reference Standard; InChI=1/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1HTên gọi khác